ESCAPE Bio logo

ESCAPE Bio

South San Francisco, CA

Escape Bio, Inc. operates as a preclinical stage biopharmaceutical company. The Company discovers and develops small molecule drugs and medicines to treat genetically-defined subpopulations in neurodegenerative diseases. Escape Bio serves customers in the State of California.

escapebio.com

Company Details

Founded

2015

Employees

Between 20 - 50 employees

Raised

$187,076,080

Headquarters Location

South San Francisco, CA

Public

No

Acquired

No

CEO

Julie Anne SmithJulie Anne Smith

Founders

Yadong Huang

Company Collections

These are collections ESCAPE Bio is a part of. Click on the collection name to view similar companies.

ESCAPE Bio Headquarters Location

4000 Shoreline Ct suite 400, South San Francisco, CA 94080

Total Amount Raised: $187,076,080

ESCAPE Bio Funding Rounds

  • Series B

    $73,000,000

    Series B Investors

    Wellington Management
    Surveyor Capital
    Avidity Partners
    CAM Capital
    New Leaf Ventures
    Johnson & Johnson Innovation
    Osage University Partners II
    OrbiMed Advisors
    Novartis Venture Fund
    Novo Holdings
    Sphera Funds Management
    Sutter Hill Ventures
    Rock Springs Capital
  • Series Unknown

    $31,073,380

  • Series A

    $63,000,000

    Series A Investors

    OrbiMed Advisors
    Novo Holdings
    Johnson & Johnson Robotics and Digital Solutions
    Novartis Venture Fund
    Osage University Partners II
    Sutter Hill Ventures
  • Series Unknown

    $20,002,700

Funding info provided by Diffbot.

ESCAPE Bio Reviews

0 out of 5 stars

Based on 0 reviews

Review data

Share your thoughts

Worked here? Share your experience. Help others decide if this company is right for them. Write a review on ESCAPE Bio.

Recent reviews